Sort
11,323 grants matching “glioblastoma”
Oligonucleotide Synthesis & NanoConstructs Core
$290,809Teri Wang Odom · Northwestern University At Chicago · U54 · FY2017 · CA
Regulation of TGF-beta Signaling and Embryonic Development by GTPases
$290,742Gerald H Thomsen · State University New York Stony Brook · R01 · FY2007 · GM
Targeted EGFR Antisense Gene Therapy of Brain Cancer
$290,737Armagen Technologies, Inc. · R43 · FY2005 · CA
Replication Stress Signatures
$290,658Raymond J Monnat · University Of Washington · P01 · FY2019 · CA
Project 3 Gene Mediated Cytotoxic Immmunotherapy for GBM
$290,642E. Antonio Chiocca · Massachusetts General Hospital · P01 · FY2021 · CA
Project 3 Gene Mediated Cytotoxic Immmunotherapy for GBM
$290,642E. Antonio Chiocca · Massachusetts General Hospital · P01 · FY2020 · CA
Project 3 Gene Mediated Cytotoxic Immmunotherapy for GBM
$290,642E. Antonio Chiocca · Massachusetts General Hospital · P01 · FY2018 · CA
Dual Targeting of DNA Repair and p53 pathways for treatment of brain cancer
$290,641Karen Elizabeth Pollok · Indiana University Indianapolis · R01 · FY2013 · CA
HSP27: A modulator and therapeutic target of SPARC-induced glioma invasion.
$290,565Sandra Ann Rempel · Corewell Health · R01 · FY2014 · CA
Interaction of thrombospondin-1 with alpha9beta1 integrin in glioma angiogenesis
$290,500Cezary Marcinkiewicz · Temple Univ Of The Commonwealth · R01 · FY2009 · CA
MRI Contrast Agent Methods to Assess Tumor Angiogenesis
$290,469Kathleen Marie Schmainda · Medical College Of Wisconsin · R01 · FY2015 · CA
MRI Contrast Agent Methods to Assess Tumor Angiogenesis
$290,469Kathleen Marie Schmainda · Medical College Of Wisconsin · R01 · FY2016 · CA
Molecular Combinatorial Therapy of Glioblastoma Multiforme
$290,398Waldemar Debinski · Wake Forest University Health Sciences · R01 · FY2014 · CA
Novel role of STAT3 in NPM/ALK-induced oncogenesis
$290,381Mariusz A Wasik · University Of Pennsylvania · R01 · FY2012 · CA
Novel role of STAT3 in NPM/ALK-induced oncogenesis
$290,381Mariusz A Wasik · University Of Pennsylvania · R01 · FY2011 · CA
Activated EGF Receptor in Ovarian Cancer
$290,263University Of New Mexico · R01 · FY2003 · CA
Cath B and muPAR siRNA constructs regressed glioma growth
$290,262Jasti S Rao · University Of Illinois At Chicago · R01 · FY2007 · CA
Cath B and muPAR siRNA constructs regressed glioma growth
$290,262Jasti S Rao · University Of Illinois At Chicago · R01 · FY2008 · CA
Cath B and muPAR siRNA constructs regressed glioma growth
$290,262Jasti S Rao · University Of Illinois At Chicago · R01 · FY2009 · CA
Cas Protein Regulation of EMT in Cancer
$290,163Erica A Golemis · Research Inst Of Fox Chase Can Ctr · R01 · FY2008 · CA
Targeted MV-CEA as a Potent Antitumor Agent against GBM
$290,159Evanthia Galanis · Mayo Clinic Rochester · P50 · FY2007 · CA
Differential Mapping of Stem Cells in Tumors
$290,114David M. Lubman · University Of Michigan At Ann Arbor · R01 · FY2013 · GM
Differential Mapping of Stem Cells in Tumors
$289,931David M. Lubman · University Of Michigan At Ann Arbor · R01 · FY2014 · GM
Novel Image-guided, remote-controlled opening of the blood-brain barrier for systemic brain tumor therapy
$289,876Akiva Mintz · Wake Forest University Health Sciences · P01 · FY2017 · CA
Activated EGF Receptor in Ovarian Cancer
$289,786University Of New Mexico · R01 · FY2004 · CA